Attgeno
Stockholm, SE · 2 known investors
Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients. The company works in the biotech and drug development field across specific disease areas.
Founders & leadership
LE
Lars E. GustafssonCo-founder (deceased)
Board
MP
Investors · 2
In the news
Frequently asked questions
- What does Attgeno do?
- Attgeno is a pharmaceutical company developing Supernitro, a therapy focused on the targeted delivery of nitric oxide to treat critically ill patients. The company works in the biotech and drug development field across specific disease areas.
- Who founded Attgeno?
- Attgeno was founded by Lars E. Gustafsson.
- Who are Attgeno's investors?
- Attgeno's investors include EIR Ventures, Hadean Ventures.
- Where is Attgeno headquartered?
- Attgeno is headquartered in Stockholm, SE.